Skip to search formSkip to main contentSkip to account menu

Cialis

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Highly Cited
2010
Highly Cited
2010
2010
2010
Review
2006
Review
2006
New oral drugs, especially phosphodiesterase type 5 (PDE5) inhibitors, have revolutionalised the treatment of erectile… 
Review
2002
Review
2002
Tadalafil is an inhibitor of phosphodiesterase type 5, and is currently undergoing regulatory review in the US and in Europe. Its… 
Review
2002
Review
2002
  • H. Porst
  • International Journal of Impotence Research
  • 2002
  • Corpus ID: 36282218
IC351 (tadalafil, trade name Cialis) is a new representative compound of the second generation of selective phosphodiesterase 5… 
Highly Cited
2001
Highly Cited
2001
IC351 (Cialis™) is a selective inhibitor of PDE5. The efficacy and safety of on-demand dosing of IC351 in men with erectile… 
Highly Cited
1997
Highly Cited
1997
Methods of physiological energetics were applied to compare growth rates of mussels Mytilus galloprovincialis Lmk from 2 habitats…